Testing

New Tests Launched in February

In February 2017, Mayo Medical Laboratories announced nine brand new tests along with numerous reference-value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • March 9, 2017
Infliximab Test Now Validated for Inflectra

Mayo Clinic has completed validation of its existing Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum test for the new biosimilar drug Inflectra. Clients[...]

By Mayo Clinic Laboratories • March 7, 2017
The Metabolic Autopsy: Postmortem Screening in Cases of Sudden, Unexpected Death

In cases of sudden or unexpected death, autopsy evaluation can include a biochemical analysis to identify deaths caused by fatty acid oxidation disorders.

By Communiqué Archive • November 16, 2016
Gastrointestinal Pathogen Panel, PCR, Feces [Test in Focus]

The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

By Brent Westra • March 10, 2016